Corbus Pharmaceuticals Holdings Inc (CRBP)
17.72
-0.26
(-1.45%)
USD |
NASDAQ |
Nov 27, 13:52
Corbus Pharmaceuticals Holdings 1 Year Total Returns (Daily): 314.3% for Nov. 26, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 26, 2024 | 314.3% |
November 25, 2024 | 313.6% |
November 22, 2024 | 306.3% |
November 21, 2024 | 298.3% |
November 20, 2024 | 249.6% |
November 19, 2024 | 259.2% |
November 18, 2024 | 263.6% |
November 15, 2024 | 268.3% |
November 14, 2024 | 353.5% |
November 13, 2024 | 475.0% |
November 12, 2024 | 452.0% |
November 11, 2024 | 472.0% |
November 08, 2024 | 391.6% |
November 07, 2024 | 341.0% |
November 06, 2024 | 275.2% |
November 05, 2024 | 266.2% |
November 04, 2024 | 250.1% |
November 01, 2024 | 235.0% |
October 31, 2024 | 192.8% |
October 30, 2024 | 202.4% |
October 29, 2024 | 210.9% |
October 28, 2024 | 213.6% |
October 25, 2024 | 185.1% |
October 24, 2024 | 185.4% |
October 23, 2024 | 186.5% |
Date | Value |
---|---|
October 22, 2024 | 191.0% |
October 21, 2024 | 194.5% |
October 18, 2024 | 206.8% |
October 17, 2024 | 209.5% |
October 16, 2024 | 217.8% |
October 15, 2024 | 212.9% |
October 14, 2024 | 210.0% |
October 11, 2024 | 209.4% |
October 10, 2024 | 194.1% |
October 09, 2024 | 190.7% |
October 08, 2024 | 204.0% |
October 07, 2024 | 194.9% |
October 04, 2024 | 211.9% |
October 03, 2024 | 217.5% |
October 02, 2024 | 212.3% |
October 01, 2024 | 185.3% |
September 30, 2024 | 206.1% |
September 27, 2024 | 229.4% |
September 26, 2024 | 234.2% |
September 25, 2024 | 252.3% |
September 24, 2024 | 169.7% |
September 23, 2024 | 179.3% |
September 20, 2024 | 188.6% |
September 19, 2024 | 648.2% |
September 18, 2024 | 594.8% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.53%
Minimum
Oct 19 2022
1.99K%
Maximum
Mar 13 2024
52.78%
Average
-32.63%
Median
1 Year Total Returns (Daily) Benchmarks
AIM ImmunoTech Inc | -47.64% |
Perspective Therapeutics Inc | 72.68% |
Protalix BioTherapeutics Inc | 17.48% |
Electromed Inc | 193.7% |
Armata Pharmaceuticals Inc | 15.76% |